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CD28 knockout mice as a useful clue to examine the pathogen- antibodies that are directed against various nuclear anti-
esis of chronic graft-versus-host reaction. gens (Ags). Any organ in the body may be affected.
Background. Injection of BALB/c or DBA/2 spleen cells Development of renal disease, carrying an ominous prog-into F1 C57BL/6 (B6) hybrids induces a graft-versus-host reac-
nosis, is seen in 50 to 80% of patients with SLE [1],tion (GVHR) of a chronic stimulatory type that results in
resulting in end-stage renal failure requiring renal re-clinical and pathologic manifestations that resemble the human
systemic lupus erythematosus (SLE). The aim of the present placement therapy in 10 to 20% of these patients [2]. The
study was to examine the role of a major T-cell costimulatory pathogenic mechanism responsible for lupus nephritis is
signal receptor, CD28, in the production of autoantibody and still not fully understood. Research into the pathogenesisthe development of an immune complex glomerulonephritis,
of SLE has been hampered by the parsimonious numberwhich are common in SLE pathology.
of well-defined animal models. One of the few acceptedMethods. For this purpose, CD28-deficient (CD28KO) mice
were used for the source of donor lymphocytes. Chronic GVHR animal models of this disease uses C57BL/6 (B6) back-
was induced by an injection of BALB/c or BALB. CD28KO ground F1 hybrid mice into which either parental DBA/2
donor cells into normal BCF1 mice. Serum titers of anti-dsDNA
or BALB/c spleen cells are injected [3–6]. The basicantibodies were assessed by enzyme-linked immunosorbent
paradigm of this model is the stimulation of donor CD41assay (ELISA) and major histocompatibility complex (MHC)
class II antigen expression on B cells were tested by flow cytom- T cells by disparate class II structures expressed on F1
etry. In addition, depositions of immunoglobulin (Ig) were recipient cells. This results in an abnormal T-B coopera-
examined by direct immunofluorescence staining on frozen tion in which the alloreactive donor Th cells induce the
kidney sections.
polyclonal activation of recipient/host B cells. B-cellResults. When (BALB/c 3 B6)F1 mice were injected with
numbers increase several-fold in spleen and lymphparental BALB/c lymphocytes, serum anti-dsDNA titer was
significantly increased in association with nonspecific B-cell nodes, and hypergammaglobulinemia, the generation of
activation and IgG deposition in the glomerular basement mem- various autoantibodies, and an immune complex glomer-
brane. In sharp contrast, none of these signs were observed in ulonephritis are commonly accompanied. These clinicalF1 mice, which were injected with CD28KO spleen cells.
pathologies are particularly similar to SLE, but the mech-Conclusion. The CD28-mediated T-cell costimulatory path-
anisms underlying the development of this pathology areway plays a pivotal role in the development of polyclonal B-cell
activation, autoantibody production, and an immune complex not well understood [7].
glomerulonephritis. We propose that CD28KO mice are useful Primary T-cell activation in vivo requires both engage-
clues in examining the pathogenesis of experimental lupus ne- ment of the T-cell receptor (TCR) and an independentphritis.
costimulatory signal induced by the Ag-presenting cell
(APC). In particular, signal transduction through the
CD28 costimulatory pathway plays a critical role in regu-Systemic lupus erythematosus (SLE) is an autoimmune
lating the initial response of a T cell to Ag [8]. Blockingdisease characterized by the production of multiple auto-
the interaction of these costimulatory molecules leads
to the inhibition of T-cell proliferation and, under some
circumstances, induction of either Ag-specific hypore-Key words: lupus nephritis, CD28 knockout mice, immune complex glo-
merulonephritis, polyclonal B cell activation, autoantibody production. sponsiveness or anergy [9, 10]. Based on this observation,
several investigators have used human CTLA4Ig to in-Received for publication March 3, 1999
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Fig. 1. Expansion of donor CD41 T cells and
host B cells in chronic graft-versus-host reac-
tion (GVHR) mice. One, 3, and 12 weeks after
injection of donor spleen cells, GVHR spleen
cells were counted and stained for host-spe-
cific (H-2b) class I and CD4 (A) or B220 (B).
The absolute number of donor CD41 T cells
(A) or host B cells (B) was calculated by refer-
ence to total spleen cells and percentage of
H-2b2/CD41 or H-2b1/B2201, respectively.
These are representative results of five experi-
ments. Symbols are: ( ) BALB/c; (j) BALB
CD28KO.
Fig. 2. Surface expression of major histo-
compatibility complex (MHC) class II mole-
cule by host B cells. Three weeks after donor
spleen cells were transferred, host F1 mice
were sacrificed and spleen cells were isolated.
They were stained with anti-I-Ab-FITC and
anti-B220-phycoerythrin. Histograms of anti-
I-Ab reactivity of B220-positive cells are shown.
The dotted line represents staining of normal
F1 spleen cells.
lenge [11–13]. We investigated the role of CD28-medi- Induction of chronic GVHR
ated costimulatory signaling in parental F1 induced Cell suspensions were prepared in phosphate-buffered
chronic graft-versus-host reaction (GVHR) by the use saline (PBS) from the spleen cells of donors. The suspen-
of CD28 gene knockout (CD28KO) mice. Here we dem- sions were filtered through nylon mesh and 7 3 107
onstrate that CD28 costimulatory signals are essential BALB/c or BALB. CD28KO donor cells were injected
for autoantibody production and the development of into the tail vein of normal BCF1 host mice. Those mice
immune complex glomerulonephritis. were maintained in specific pathogen-free conditions.
Serologic studies
METHODS
Mice were bled at the times indicated, and sera were
Mice tested by enzyme-linked immunosorbent assay (ELISA)
Six- to eight-week-old BALB/c, C57BL/6 (B6), and for the presence of IgG1 Ab to dsDNA as previously
(BALB/c 3 B6)F1 (BCF1) mice were obtained from described [15, 16].
the Japanese SLC Co. Ltd. (Hamamatsu City, Japan).
Immunofluorescence staining and flow cytometryCD28KO mice were generated as previously described
[14] and were kindly provided by Drs. K. Lee and C. Immunofluorescence staining was carried out as pre-
June (Naval Medical Research Institute, Bethesda, MD, viously described [11]. The B-cell hybridoma, Y-3P, pro-
USA). These mice were backcrossed to the BALB/c ducing a mouse monoclonal Ab (mAb, IgG2a) specific
(BALB.CD28KO) and maintained at the Research Insti- for I-Ab, was obtained from the American Type Culture
tute for Biological Sciences, Science University of Tokyo Collection (Rockville, MD, USA). The mAb was puri-
(Tokyo, Japan). The mice used in this study were back- fied from culture supernatant of Y-3P and fluorescein-
labeled according to standard techniques. Phycoerythrin-crossed for four to eight generations.
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conjugated B220 was purchased from PharMingen (San
Diego, CA, USA). Two-color flow cytometric analysis
was performed on a FACSORT using Cellquest software
(Becton Dickinson, Mountain View, CA, USA).
Histology and immunohistochemistry
Kidneys were removed, and paraffin-embedded sec-
tions were stained with periodic acid-Schiff (PAS) ac-
cording to standard procedures. For immunofluores-
cence staining, a part of kidney tissues were immediately
frozen in liquid nitrogen. Frozen sections (4 mm) were
dried and fixed in acetone for 10 minutes. For the detec-
tion of Ig deposits, sections were incubated with fluores-
cein-labeled goat anti-mouse Ig (g-chain specific; Sigma,
St. Louis, MO, USA) for 30 minutes at room temperature
and were extensively washed with PBS. Specific staining
was visualized by a fluorescence microscope. For elec-
tron microscopic analysis, small pieces of renal tissues
were fixed in 1% osmic acid and were embedded in
Fig. 3. Development of anti-dsDNA antibodies in chronic GVHRepoxy resin. Ultrathin sections were double stained with
mice. Sera of normal BALB/c-injected (s) or CD28KO-injected (d)uranyl acetate and lead citrate and were then examined mice were assayed for reactivity with dsDNA antibody. The mean
with Hitachi H-800. reactivity with SD at various time points of sera is shown.
RESULTS
Polyclonal B cell activation and anti-dsDNA liferative type of glomerulonephritis when evaluated by
Ab production light microscopy (Fig. 4A). However, no glomerular ab-
normality was detected in CD28KO-injected mice (Fig.To verify the role of CD28 for the development of
4B). Kidney sections from normal BALB/c-injected F1chronic GVHR, parental spleen cells from BALB/c do-
mice show a granular linear staining pattern of IgG de-nors were injected into uniradiated BDF1 mice recipients
posits along the glomerular capillary walls (Fig. 4C),to compare the ability of CD28KO and CD28 wild-type
whereas sparse IgG were detected in mesangial areas in(WT) T cells to mount a chronic GVHR. In chronic
the kidney sections of CD28KO-injected mice (Fig. 4D).GVHR, donor CD41 T cells are stimulated by class II
There was no difference in the glomerular C3 depositionAg on host B cells and, in turn, stimulate these B cells
in both normal BALB/c-injected (Fig. 4E) and CD28KO-to become activated and produce increased levels of Igs,
injected mice (Fig. 4F). Electron microscopy confirmedincluding autoantibodies [3–7]. Indeed, in WT-injected
that IgG deposits in normal BALB/c-injected F1 miceF1 mice, donor CD41 T cells demonstrated a strong
were localized in subepithelial lesions of glomerular base-expansion (Fig. 1A). Furthermore, B cells are activated,
ment membrane (Fig. 5A), despite the fact that no IgGas evidenced by the increased expression of class II Ag
deposits appeared in CD28KO-injected mice (Fig. 5B).in these mice (Fig. 2), and autoantibodies are produced,
including anti-dsDNA (Fig. 3). In contrast, CD28KO-
injected F1 mice did not demonstrate an extensive
DISCUSSIONexpansion of donor CD41 T cells, and host B cells did
Chronic GVHR in mice is a model for lupus nephritis.not up-regulate the expression of class II Ag (Fig. 2),
Recipient B cells are polyclonally activated by anti-allo-although a significant early expansion was observed (Fig.
MHC class II of donor CD41 T cells, which leads to a1B). Finally, anti-dsDNA autoantibodies were not pro-
lupus-like autoimmune syndrome [3–7]. In this model,duced (Fig. 3). These results clearly indicated that CD28-
a defect in the donor CD81 T cells with a decreasedmediated costimulatory signals are crucial for the devel-
interferon-g production results in uncontrolled prolifera-opment of chronic GVHR.
tion of recipient B cells [17]. The recipient mice develop
Immune complex deposits in kidney a variety of pathological alterations associated with the
formation of autoantibodies [18]. Gribben et al showedEighteen weeks after the induction of GVHR, all mice
that the reduction of donor T-cell responsiveness to hostwere sacrificed, and their kidneys were evaluated for the
alloantigens to levels less than that predictive for thepresence of immune complex deposits. The majority of
normal BALB/c-injected F1 mice showed a slightly pro- occurrence of severe GVHR requires the delivery of a
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Fig. 4. Histologic patterns of chronic GVHR
mice. Light micrographs of glomeruli showing
slight hypercellularity in normal BALB/c-
injected mice (A) and almost normal findings
in CD28KO-injected mice (B). Magnification
3200. Immunofluorescence micrographs dem-
onstrating IgG deposits in a granular pattern
along the glomerular basement membrane in
normal BALB/c-injected mice (C), whereas
slight deposition of IgG in mesangial area
in CD28KO-injected mice (D). Magnification
3200. There was no difference in the glomerular
C3 deposition both normal BALB/c-injected
mice (E) and CD28KO-injected mice (F).
Magnification 3200.
TCR-mediated signal concomitant with complete or near lymphocyte-injected mice, in order to determine whether
this was due to a selective defect to stimulate B cells orcomplete blockade of B7 family-mediated costimulation
[19]. However, it is not fully understood how CD28- due to a defect in the engagement of T cells or both.
We found that in WT lymphocyte-injected mice, not onlymediated signals play a role and whether CTLA4, an-
other receptor of B7 molecules, is involved in the induc- donor BALB/c T cells but also host BCF1-derived T cells
increased the expression of CD69, which is consideredtion of chronic GVHR.
The present studies show that chronic GVHR induced a marker of early activation stage of lymphocytes (data
not shown). This alteration of CD69 expression on T cellswith CD28KO lymphocytes does not result in anti-
dsDNA Ab production or in the deposition of immune was not observed in CD28KO-injected mice. These re-
sults strongly suggested that the lack of autoantibodycomplexes within glomeruli, indicating that the CD28/B7
pathway plays a critical role in these pathologies of chronic production and the development of glomerulonephritis
in CD28KO-injected mice was due to a failure to activateGVHR. We compared the activation status of T cells
in WT lymphocyte-injected mice with that of CD28KO of host-reactive T cells, which normally trigger the poly-
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Fig. 5. Electron microscopic findings of im-
mune deposits in the glomerular basement
membrane of chronic GVHR mice. Electron
micrographs show subepithelial electron dense
deposits in normal BALB/c-injected mice (A)
and no deposition in the glomerular basement
membrane of CD28KO-injected mice (B).
Magnification 32500.
clonal stimulation of both B cells and T cells in host or both anti–B7-1 and anti–B7-2 Abs were sufficient to
block anti-dsDNA Ab production, whereas anti–B7-1mice. Consistent with our hypothesis, Chen et al have
recently reported that chronic GVHR can not be induced Ab itself was insufficient [22]. Although these results
suggest the importance of the CD28 and B7-2 interactionin mice lacking CD41 T cells [20].
Delivery of a costimulatory signal through the CD28/B7 for the induction of chronic GVHR, the administration
of these Abs could also cross-link B7 present on activatedpathway is crucial in T-cell activation and differentiation.
Most of the studies for the physiological and pathological T cells [24], altering T-cell function and cytokine release.
The effect of B7/CTLA4 interaction in chronic GVHRrole of costimulatory signal have relied on administering
the fusion protein CTLA4-Ig or neutralizing anti–B7-1 remains unknown. We have recently observed that pre-
treatment of chronic GVHR induced mice with anti-or anti–B7-2 mAbs as blocking reagents for CD28 and
CTLA4 engagement [21–23]. We and others have stud- CTLA4 Ab resulted in the development of a contrasting
acute GVHR (unpublished observations). Interestingly,ied the role of B7-1 and B7-2 in chronic GVHR by
injecting GVHR-induced mice with anti–B7-1, anti–B7-2, this shift from chronic GVHR to acute GVHR by anti-
CTLA4 Ab treatment was not observed in CD28KO-or both anti-B7 Abs. Treatment with either anti–B7-2
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